Published: 2019 July 02

Parkinson’s disease Therapeutics Market Size, Competitive Landscape and Market Forecast - 2029

SKU : PH1366
180 pages
Report Summary
Table of Contents
List of Tables & Figures

Global Parkinson’s disease Therapeutics Market is segmented By Drug Class (Levodopa Combination, Dopamine Agonists, Monoamine Oxidase B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT) Inhibitors, Others (includes Anticholinergic Drugs, Antihistaminics)), By Route of Administration (Oral, Transdermal, Subcutaneous, Others (Intestinal Infusion)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online sales), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029


Market Overview

The Global "Parkinson’s disease Therapeutics Market" is expected to grow at a high CAGR of 12.4% during the forecasting period (2022-2029).

Trending Topics:

Patient Derived Xenograft (PDX) Models Market

Minoxidil Market

Krabbe Disease Treatment Market

Buy this report
Single User
Multiple User
Enterprise User
Proceed to Buy